Development, Optimization, and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold

dc.contributor.author	Forster, Michael
dc.contributor.author	Dimitrov, Teodor
dc.contributor.author	Holstein, Julia
dc.contributor.author	Gehringer, Matthias
dc.contributor.author	Ghoreschi, Kamran
dc.contributor.author	Döring, Eva
dc.contributor.author	Laufer, Stefan
dc.date.accessioned	2019-11-12T12:53:17Z
dc.date.available	2019-11-12T12:53:17Z
dc.date.issued	2018
dc.identifier.issn	1520-4804
dc.identifier.uri	http://hdl.handle.net/10900/94620
dc.language.iso	en	de_DE
dc.publisher	Amer Chemical Soc	de_DE
dc.relation.uri	http://dx.doi.org/10.1021/acs.jmedchem.8b00571	de_DE
dc.subject.ddc	540	de_DE
dc.title	Development, Optimization, and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_02180
utue.publikation.seiten	5350-5366	de_DE
utue.personen.roh	Forster, Michael
utue.personen.roh	Chaikuad, Apirat
utue.personen.roh	Dimitrov, Teodor
utue.personen.roh	Doering, Eva
utue.personen.roh	Holstein, Julia
utue.personen.roh	Berger, Benedict-Tilman
utue.personen.roh	Gehringer, Matthias
utue.personen.roh	Ghoreschi, Kamran
utue.personen.roh	Mueller, Susanne
utue.personen.roh	Knapp, Stefan
utue.personen.roh	Laufer, Stefan A.
dcterms.isPartOf.ZSTitelID	Journal of Medicinal Chemistry	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	61	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE